Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35. (Q40152394)

18 September 2017

Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35. (English)

1 reference

18 September 2017

Mari Yamada

1

1 reference

18 September 2017

Taro Saito

2

1 reference

18 September 2017

Yutaka Sato

3

1 reference

18 September 2017

Yusei Kawai

4

1 reference

18 September 2017

Akio Sekigawa

5

1 reference

18 September 2017

Yuko Hamazumi

6

1 reference

18 September 2017

Akiko Asada

7

1 reference

18 September 2017

Mitsuhito Wada

8

1 reference

18 September 2017

Hirofumi Doi

9

1 reference

18 September 2017

Shin-Ichi Hisanaga

10

1 reference

18 September 2017

language of work or name

English

0 references

publication date

29 March 2007

1 reference

Journal of Neurochemistry

18 September 2017

1 reference

18 September 2017

102

1 reference

18 September 2017

5

1 reference

18 September 2017

1477-1487

1 reference

Changes in the expression of novel Cdk5 activator messenger RNA (p39nck5ai mRNA) during rat brain development.

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Synaptic localization of p39, a neuronal activator of cdk5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Phosphorylation states of microtubule-associated protein 2 (MAP2) determine the regulatory role of MAP2 in microtubule dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

The cyclin-dependent kinase 5 activator, p39, is expressed in stripes in the mouse cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

A specific interaction between muskelin and the cyclin-dependent kinase 5 activator p39 promotes peripheral localization of muskelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

In vivo and in vitro phosphorylation at Ser-493 in the glutamate (E)-segment of neurofilament-H subunit by glycogen synthase kinase 3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Microtubule-stimulated phosphorylation of tau at Ser202 and Thr205 by cdk5 decreases its microtubule nucleation activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

Cyclin-dependent Kinase 5 (Cdk5) Activation Domain of Neuronal Cdk5 Activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04505.X

10.1111/J.1471-4159.2007.04505.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference